1. Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 2008; 139:495–505. PMID:
18922334.
Article
2. Blitzer A, Brin MF. The dystonic larynx. J Voice. 1992; 6:294–297.
Article
3. Miler RH. Technique of percutaneous EMG-guided botulinum toxin injection of the larynx for spasmodic dystonia. J Voice. 1992; 6:377–379.
4. Davis PJ, Boone DR, Carroll RL, Darveniza P, Harrison GA. Adductor spastic dysphonia: heterogeneity of physiologic and phonatory characteristics. Ann Otol Rhinol Laryngol. 1988; 97(2 Pt 1):179–185. PMID:
3355046.
Article
5. Yu P, Ouaknine M, Revis J, Giovanni A. Objective voice analysis for dysphonic patients: a multiparametric protocol including acoustic and aerodynamic measurements. J Voice. 2001; 15:529–542. PMID:
11792029.
6. Logemann JA. Evaluation and treatment of swallowing disorders. 2nd ed. Austin: Pro-Ed;1998.
7. Blitzer A, Brin MF. Laryngeal dystonia: a series with botulinum toxin therapy. Ann Otol Rhinol Laryngol. 1991; 100:85–89. PMID:
1992905.
Article
8. Kieschnick CO, Powell TW. Treatment of spasmodic dysphonia: a brief overview for clinicians. Natl Stud Speech Lang Hear Assoc J. 1996; 23:14–18.
Article
9. Banoub M, Rao U, Motta P, Tetzlaff JE, Eliachar I, Blitzer A. Recurrent postoperative stridor requiring tracheostomy in a patient with spasmodic dysphonia. Anesthesiology. 2000; 92:893–895. PMID:
10719977.
Article
10. Pool KD, Freeman FJ, Finitzo T, Hayashi MM, Chapman SB, Devous MD Sr, et al. Heterogeneity in spasmodic dysphonia: neurologic and voice findings. Arch Neurol. 1991; 48:305–309. PMID:
2001189.